Metformin in the Treatment of Polycystic Ovary Syndrome

  • Beatriz Motta D
14Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Polycystic ovary syndrome (PCOS) is one of the most frequent diseases that affects women in their reproductive age. The heterogeneity of PCOS makes not only the diagnosis but also the choice of an adequate treatment difficult. The biguanide, N, N' dimethyl-biguanide : Metformin is an antidiabetic drug that increases glucose utilization in insulin-sensitive tissues and is useful in the reduction of both insulin resistance and circulating androgens as well as restoring ovulation. However, metformin is being clinically used without a complete understanding of the mechanism involved. The present review explores some of the actions and efficacy of metformin in the treatment of PCOS during different reproductive periods. © 2008 Bentham Science Publishers Ltd.

Cite

CITATION STYLE

APA

Beatriz Motta, D. (2008). Metformin in the Treatment of Polycystic Ovary Syndrome. Current Pharmaceutical Design, 14(21), 2121–2125. https://doi.org/10.2174/138161208785294609

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free